Sinopharm Group Co. Ltd. (SHTDY)
OTC: SHTDY
· Real-Time Price · USD
11.88
-0.08 (-0.67%)
At close: Oct 06, 2025, 12:48 PM
Sinopharm Cash Flow Statement
Financials in CNY. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Net Income | 3.46B | 3.35B | 3.7B | 4.95B | 4.1B | n/a | 3.69B | 4.18B | 3.58B |
Depreciation & Amortization | 2.23B | 2.4B | 2.33B | 2.31B | 2.1B | n/a | 2B | 1.9B | 1.88B |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | -5.46B | 5.46B | -2.04B | 5.74B | n/a | -3.31B | 1.03B | -610.45M |
Other Non-Cash Items | -39.8B | -14.58B | 14.34B | -7.97B | 22.36B | 55.26B | 8.98B | 11.81B | 16.59B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 61.37B | -61.37B | 61.21B | -71.89B | n/a | -48.97B | 19.18B | -49.83B |
Operating Cash Flow | -34.11B | 52.54B | -40.99B | 60.5B | -43.33B | 55.26B | -34.29B | 37.08B | -27.77B |
Capital Expenditures | -670.7M | -1.44B | -1.02B | -1.24B | -719.37M | -945.08M | -870.08M | -1.28B | -791.96M |
Cash Acquisitions | n/a | 102.01M | -102.01M | 42.54M | -25.92M | -233.31M | -163.07M | -263.92M | -233.3M |
Purchase of Investments | n/a | n/a | n/a | 61.51M | n/a | 78.46M | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | -150.49M | n/a | -63.84M | n/a | n/a | n/a |
Other Investing Acitivies | 139.46M | -1.38B | 86.63M | -251.08M | 1.93B | -1.6B | 1.42B | 190.6M | 1.11B |
Investing Cash Flow | -531.24M | -2.71B | -1.04B | -957.39M | 1.18B | -2.57B | 391.02M | -1.36B | 88.3M |
Debt Repayment | 18.71B | n/a | 23.87B | -25.18B | n/a | -15.61B | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -2.14B | -2.71B | -2.34B | -2.56B | n/a | n/a | n/a | -2.15B | n/a |
Other Financial Acitivies | -991.34M | -36.12B | 23.03M | -1.2B | 21.3B | -7.8B | 22.51B | -24.4B | 11.86B |
Financial Cash Flow | 15.58B | -38.84B | 21.55B | -28.94B | 21.3B | -23.41B | 22.51B | -26.55B | 11.86B |
Net Cash Flow | 35.24B | -43.33B | 43.33B | 30.55B | -20.84B | 26.39B | -11.38B | 9.17B | -15.82B |
Free Cash Flow | -34.78B | 51.1B | -42.02B | 59.26B | -44.05B | 51.45B | -35.16B | 35.79B | -28.56B |